An oral, Smac mimetic that also serves as an inhibitor of apoptosis proteins: XIAP, cIAP1, and cIAP2. AT-406 has been shown to inhibit the survival of cancer cells and is currently in phase 1 clinical trials for human cancer treatment.
|Purity||>99.0% (HPLC), NMR(conforms)|
|Molecular Weight||561.71 Da|
|Physical State||Lyophilized solid|
|Solubility||DMSO (112mg/ml); Ethanol (<112mg/ml);Water (<1mg/ml)|
|Storage||4°C, (-20°C Long term). The product can be shipped at room temperature.|